<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>5213</number>
    <updateDate>2023-01-14T22:48:42Z</updateDate>
    <updateDateIncludingText>2023-01-14T22:48:42Z</updateDateIncludingText>
    <originChamber>House</originChamber>
    <originChamberCode>H</originChamberCode>
    <type>HR</type>
    <introducedDate>2004-10-05</introducedDate>
    <congress>108</congress>
    <committees>
      <item>
        <systemCode>hswm00</systemCode>
        <name>Ways and Means Committee</name>
        <chamber>House</chamber>
        <type>Standing</type>
        <subcommittees>
          <item>
            <systemCode>hswm02</systemCode>
            <name>Health Subcommittee</name>
            <activities>
              <item>
                <name>Referred to</name>
                <date>2004-10-08T18:41:48Z</date>
              </item>
            </activities>
          </item>
        </subcommittees>
        <activities>
          <item>
            <name>Referred to</name>
            <date>2004-10-05T13:03:10Z</date>
          </item>
        </activities>
      </item>
      <item>
        <systemCode>hsif00</systemCode>
        <name>Energy and Commerce Committee</name>
        <chamber>House</chamber>
        <type>Standing</type>
        <subcommittees>
          <item>
            <systemCode>hsif14</systemCode>
            <name>Health Subcommittee</name>
            <activities>
              <item>
                <name>Referred to</name>
                <date>2004-10-05T16:13:18Z</date>
              </item>
            </activities>
          </item>
        </subcommittees>
        <activities>
          <item>
            <name>Referred to</name>
            <date>2004-10-05T13:03:05Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <actions>
      <item>
        <actionDate>2004-11-30</actionDate>
        <text>Became Public Law No: 108-427.</text>
        <type>President</type>
        <actionCode>E40000</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2004-11-30</actionDate>
        <text>Became Public Law No: 108-427.</text>
        <type>BecameLaw</type>
        <actionCode>36000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2004-11-30</actionDate>
        <text>Signed by President.</text>
        <type>President</type>
        <actionCode>E30000</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2004-11-30</actionDate>
        <text>Signed by President.</text>
        <type>BecameLaw</type>
        <actionCode>36000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2004-11-19</actionDate>
        <text>Presented to President.</text>
        <type>Floor</type>
        <actionCode>E20000</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2004-11-19</actionDate>
        <text>Presented to President.</text>
        <type>President</type>
        <actionCode>28000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2004-11-16</actionDate>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Message on Senate action sent to the House.</text>
        <type>Floor</type>
      </item>
      <item>
        <actionDate>2004-11-16</actionDate>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Passed Senate without amendment by Unanimous Consent. (consideration: CR S11389)</text>
        <type>Floor</type>
      </item>
      <item>
        <actionDate>2004-11-16</actionDate>
        <text>Passed/agreed to in Senate: Passed Senate without amendment by Unanimous Consent.(consideration: CR S11389)</text>
        <type>Floor</type>
        <actionCode>17000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2004-10-08</actionDate>
        <committees>
          <item>
            <systemCode>hswm02</systemCode>
            <name>Health Subcommittee</name>
          </item>
        </committees>
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Referred to the Subcommittee on Health.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2004-10-08</actionDate>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Received in the Senate, read twice.</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <actionDate>2004-10-07</actionDate>
        <actionTime>11:50:20</actionTime>
        <text>Motion to reconsider laid on the table Agreed to without objection.</text>
        <type>Floor</type>
        <actionCode>H38310</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2004-10-07</actionDate>
        <actionTime>11:50:19</actionTime>
        <text>On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 418 - 0 (Roll no. 504). (text: CR 10/6/2004 H8255)</text>
        <type>Floor</type>
        <actionCode>H37300</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <recordedVotes>
          <recordedVote>
            <rollNumber>504</rollNumber>
            <url>https://clerk.house.gov/evs/2004/roll504.xml</url>
            <chamber>House</chamber>
            <congress>108</congress>
            <date>2004-10-07T15:50:19Z</date>
            <sessionNumber>2</sessionNumber>
          </recordedVote>
        </recordedVotes>
      </item>
      <item>
        <actionDate>2004-10-07</actionDate>
        <actionTime>11:50:19</actionTime>
        <text>Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 418 - 0 (Roll no. 504).(text: CR 10/6/2004 H8255)</text>
        <type>Floor</type>
        <actionCode>8000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <recordedVotes>
          <recordedVote>
            <rollNumber>504</rollNumber>
            <url>https://clerk.house.gov/evs/2004/roll504.xml</url>
            <chamber>House</chamber>
            <congress>108</congress>
            <date>2004-10-07T15:50:19Z</date>
            <sessionNumber>2</sessionNumber>
          </recordedVote>
        </recordedVotes>
      </item>
      <item>
        <actionDate>2004-10-07</actionDate>
        <actionTime>11:42:23</actionTime>
        <text>Considered as unfinished business. (consideration: CR H8650-8651)</text>
        <type>Floor</type>
        <actionCode>H30000</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2004-10-06</actionDate>
        <actionTime>16:34:04</actionTime>
        <text>At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.</text>
        <type>Floor</type>
        <actionCode>H37220</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2004-10-06</actionDate>
        <actionTime>16:23:21</actionTime>
        <text>DEBATE - The House proceeded with forty minutes of debate on H.R. 5213.</text>
        <type>Floor</type>
        <actionCode>H8D000</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2004-10-06</actionDate>
        <actionTime>16:23:19</actionTime>
        <text>Considered under suspension of the rules. (consideration: CR H8255-8257)</text>
        <type>Floor</type>
        <actionCode>H30000</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2004-10-06</actionDate>
        <actionTime>16:23:04</actionTime>
        <text>Mr. Bilirakis moved to suspend the rules and pass the bill, as amended.</text>
        <type>Floor</type>
        <actionCode>H30300</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2004-10-05</actionDate>
        <committees>
          <item>
            <systemCode>hsif14</systemCode>
            <name>Health Subcommittee</name>
          </item>
        </committees>
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Referred to the Subcommittee on Health.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2004-10-05</actionDate>
        <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hswm00</systemCode>
            <name>Ways and Means Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2004-10-05</actionDate>
        <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
        <type>IntroReferral</type>
        <actionCode>H11100-A</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2004-10-05</actionDate>
        <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2004-10-05</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>Intro-H</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2004-10-05</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>1000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>B000463</bioguideId>
        <fullName>Rep. Bilirakis, Michael [R-FL-9]</fullName>
        <firstName>MICHAEL</firstName>
        <lastName>BILIRAKIS</lastName>
        <party>R</party>
        <state>FL</state>
        <district>9</district>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>K000078</bioguideId>
        <fullName>Rep. Kelly, Sue W. [R-NY-19]</fullName>
        <firstName>SUE</firstName>
        <lastName>KELLY</lastName>
        <party>R</party>
        <state>NY</state>
        <middleName>W.</middleName>
        <district>19</district>
        <sponsorshipDate>2004-10-05</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>B000944</bioguideId>
        <fullName>Rep. Brown, Sherrod [D-OH-13]</fullName>
        <firstName>Sherrod</firstName>
        <lastName>Brown</lastName>
        <party>D</party>
        <state>OH</state>
        <district>13</district>
        <sponsorshipDate>2004-10-06</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
    </cosponsors>
    <laws>
      <item>
        <type>Public Law</type>
        <number>108-427</number>
      </item>
    </laws>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <subjects>
      <legislativeSubjects>
        <item>
          <name>Ambulatory care</name>
        </item>
        <item>
          <name>Clinical trials</name>
        </item>
        <item>
          <name>Congress</name>
        </item>
        <item>
          <name>Congressional investigations</name>
        </item>
        <item>
          <name>Congressional reporting requirements</name>
        </item>
        <item>
          <name>Digestive diseases</name>
        </item>
        <item>
          <name>Epidemiology</name>
        </item>
        <item>
          <name>Home care services</name>
        </item>
        <item>
          <name>Medicaid</name>
        </item>
        <item>
          <name>Medical research</name>
        </item>
        <item>
          <name>Medicare</name>
        </item>
        <item>
          <name>Nutrition</name>
        </item>
        <item>
          <name>Old age, survivors and disability insurance</name>
        </item>
        <item>
          <name>Paralysis</name>
        </item>
        <item>
          <name>Research centers</name>
        </item>
        <item>
          <name>Science, Technology, Communications</name>
        </item>
        <item>
          <name>Social Welfare</name>
        </item>
        <item>
          <name>Social security eligibility</name>
        </item>
        <item>
          <name>Spinal cord injuries</name>
        </item>
        <item>
          <name>Ulcers</name>
        </item>
      </legislativeSubjects>
      <policyArea>
        <name>Health</name>
      </policyArea>
    </subjects>
    <summaries>
      <summary>
        <versionCode>00</versionCode>
        <actionDate>2004-10-05</actionDate>
        <actionDesc>Introduced in House</actionDesc>
        <updateDate>2004-11-03T19:35:03Z</updateDate>
        <text><![CDATA[ <p>Research Review Act of 2004 - Requires the Secretary of Health and Human Services, in coordination with the Director of the National Institutes of Health, to report to specified congressional committees on the methods by which the Roadmap for Medical Research has advanced the use of multidisciplinary research teams and consortia of research institutions to advance treatments, develop new therapies, and collaborate on clinical trials, including with respect to spinal cord injury and paralysis research.</p> <p>Requires the Secretary, acting through the Director of the Centers for Disease Control and Prevention (CDC), to report to such committees on: (1) the epidemiological studies currently underway at such Centers, future planned studies, the criteria involved in determining what epidemiological studies to conduct, defer, or suspend, and the scope of those studies, including with respect to the inflammatory bowel disease epidemiological study; and (2) CDC activities to establish partnerships with research and patient advocacy communities to expand epidemiological studies.</p> <p>Requires the Comptroller General of the United States to study and report to Congress on: (1) Medicare and Medicaid coverage standards that apply to patients with inflammatory bowel disease for specified therapies, taking into account appropriate outpatient or home health care delivery settings; and (2) the problems patients encounter when applying for disability insurance benefits under title II of the Social Security Act and recommendations for improving the application process for patients with inflammatory bowel disease.</p>]]></text>
      </summary>
      <summary>
        <versionCode>36</versionCode>
        <actionDate>2004-10-07</actionDate>
        <actionDesc>Passed House amended</actionDesc>
        <updateDate>2004-11-03T19:38:04Z</updateDate>
        <text><![CDATA[ <p>Research Review Act of 2004 - Requires the Secretary of Health and Human Services, in coordination with the Director of the National Institutes of Health, to report to specified congressional committees on the methods by which the Roadmap for Medical Research has advanced the use of multidisciplinary research teams and consortia of research institutions to advance treatments, develop new therapies, and collaborate on clinical trials, including with respect to spinal cord injury and paralysis research.</p> <p>Requires the Secretary, acting through the Director of the Centers for Disease Control and Prevention (CDC), to report to such committees on: (1) the epidemiological studies currently underway at such Centers, future planned studies, the criteria involved in determining what epidemiological studies to conduct, defer, or suspend, and the scope of those studies, including with respect to the inflammatory bowel disease epidemiological study; and (2) CDC activities to establish partnerships with research and patient advocacy communities to expand epidemiological studies.</p> <p>Requires the Comptroller General of the United States to study and report to Congress on: (1) Medicare and Medicaid coverage standards that apply to patients with inflammatory bowel disease for specified therapies, taking into account appropriate outpatient or home health care delivery settings; and (2) the problems patients encounter when applying for disability insurance benefits under title II of the Social Security Act and recommendations for improving the application process for patients with inflammatory bowel disease.</p>]]></text>
      </summary>
      <summary>
        <versionCode>82</versionCode>
        <actionDate>2004-11-16</actionDate>
        <actionDesc>Passed Senate without amendment</actionDesc>
        <updateDate>2005-01-11T13:50:36Z</updateDate>
        <text><![CDATA[ <p><b>(This measure has not been amended since it was passed by the House on October 7, 2004. The summary of that version is repeated here.)</b></p> <p>Research Review Act of 2004 - Requires the Secretary of Health and Human Services, in coordination with the Director of the National Institutes of Health, to report to specified congressional committees on the methods by which the Roadmap for Medical Research has advanced the use of multidisciplinary research teams and consortia of research institutions to advance treatments, develop new therapies, and collaborate on clinical trials, including with respect to spinal cord injury and paralysis research.</p> <p>Requires the Secretary, acting through the Director of the Centers for Disease Control and Prevention (CDC), to report to such committees on: (1) the epidemiological studies currently underway at such Centers, future planned studies, the criteria involved in determining what epidemiological studies to conduct, defer, or suspend, and the scope of those studies, including with respect to the inflammatory bowel disease epidemiological study; and (2) CDC activities to establish partnerships with research and patient advocacy communities to expand epidemiological studies.</p> <p>Requires the Comptroller General of the United States to study and report to Congress on: (1) Medicare and Medicaid coverage standards that apply to patients with inflammatory bowel disease for specified therapies, taking into account appropriate outpatient or home health care delivery settings; and (2) the problems patients encounter when applying for disability insurance benefits under title II of the Social Security Act and recommendations for improving the application process for patients with inflammatory bowel disease.</p>]]></text>
      </summary>
      <summary>
        <versionCode>49</versionCode>
        <actionDate>2004-11-30</actionDate>
        <actionDesc>Public Law</actionDesc>
        <updateDate>2005-01-13T16:32:51Z</updateDate>
        <text><![CDATA[ <p><b>(This measure has not been amended since it was passed by the House on October 7, 2004. The summary of that version is repeated here.)</b></p> <p>Research Review Act of 2004 - Requires the Secretary of Health and Human Services, in coordination with the Director of the National Institutes of Health (NIH), to report to specified congressional committees on the methods by which the Roadmap for Medical Research has advanced the use of multidisciplinary research teams and consortia of research institutions to advance treatments, develop new therapies, and collaborate on clinical trials, including with respect to spinal cord injury and paralysis research.</p> <p>Requires the Secretary, acting through the Director of the Centers for Disease Control and Prevention (CDC), to report to such committees on: (1) the epidemiological studies currently underway at such Centers, future planned studies, the criteria involved in determining what epidemiological studies to conduct, defer, or suspend, and the scope of those studies, including with respect to the inflammatory bowel disease epidemiological study; and (2) CDC activities to establish partnerships with research and patient advocacy communities to expand epidemiological studies.</p> <p>Requires the Comptroller General of the United States to study and report to Congress on: (1) Medicare and Medicaid coverage standards that apply to patients with inflammatory bowel disease for specified therapies, taking into account appropriate outpatient or home health care delivery settings; and (2) the problems patients encounter when applying for disability insurance benefits under title II of the Social Security Act and recommendations for improving the application process for patients with inflammatory bowel disease.</p>]]></text>
      </summary>
    </summaries>
    <title>Research Review Act of 2004</title>
    <titles>
      <item>
        <titleType>Display Title</titleType>
        <title>Research Review Act of 2004</title>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <title>To expand research information regarding multidisciplinary research projects and epidemiological studies.</title>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Titles as Introduced</titleType>
        <title>Research Review Act of 2004</title>
      </item>
      <item>
        <titleType>Short Titles as Passed House</titleType>
        <title>Research Review Act of 2004</title>
        <chamberCode>H</chamberCode>
        <chamberName>House</chamberName>
      </item>
      <item>
        <titleType>Short Titles as Passed Senate</titleType>
        <title>Research Review Act of 2004</title>
        <chamberCode>S</chamberCode>
        <chamberName>Senate</chamberName>
      </item>
      <item>
        <titleType>Short Titles as Enacted</titleType>
        <title>Research Review Act of 2004</title>
      </item>
    </titles>
    <textVersions>
      <item>
        <type>Enrolled Bill</type>
        <date/>
        <formats/>
      </item>
      <item>
        <type>Received in Senate</type>
        <date>2004-10-08T04:00:00Z</date>
        <formats/>
      </item>
      <item>
        <type>Engrossed in House</type>
        <date>2004-10-07T04:00:00Z</date>
        <formats/>
      </item>
      <item>
        <type>Introduced in House</type>
        <date>2004-10-05T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-108hr5213ih/xml/BILLS-108hr5213ih.xml</url>
          </item>
        </formats>
      </item>
      <item>
        <date>2004-12-01T04:59:59Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/PLAW-108publ427/xml/PLAW-108publ427.xml</url>
          </item>
        </formats>
        <type>Public Law</type>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2004-11-30</actionDate>
      <text>Became Public Law No: 108-427.</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
